Gauss Surgical’s flagship product, Triton, monitors blood loss in real time using an iPad. It captures rapid scans of blood-containing sponges and canisters utilizes machine learning to estimate blood loss. It received de novo approval from the FDA as well as a European CE mark. It is currently being used in 50 hospitals.
The company plans on using the funds to increase the adoption of Triton in hospitals and to develop new AI-driven applications for the operating room.
The strategic venture arms of the following health systems participated in the round:
● New Hyde Park, N.Y.-based Northwell Health
● Raleigh, N.C.-based UNC REX Healthcare
● Peoria, Ill.-based OSF Healthcare
● Renton, Wash.-based Providence Health & Services
● Orlando (Fla.) Health
● Grand Rapids, Mich.-based Spectrum Health
● New York City-based Mount Sinai Health System
● Houston-based Memorial Hermann Health System
More articles on artificial intelligence:
IBM says its new services ‘open the black box of AI’
Google Cloud taps Carnegie Mellon professor to lead AI
Mayo Clinic, Mass General, Nvidia researchers use AI to create ‘synthetic MRIs’
